Background/Objectives: Dietary factors have been associated with metabolic syndrome (MS) in healthy individuals and specific ethnic groups. To evaluate possible associations of usual dietary factors with the presence of MS in patients with type 2 diabetes mellitus (DM). Subjects/Methods: In this cross-sectional study, 214 patients with type 2 DM without dietary counseling during previous 6 months were studied. After clinical and laboratory examinations, dietary intake was evaluated by 3-day weighed-diet records, whose reliability was confirmed by 24-h urinary nitrogen output. The presence of MS was defined according to International Diabetes Federation. Results: Patients with MS (n ¼ 174) had a lower intake of total (16.776.2 vs 19.576.5 g day À1 ; P ¼ 0.010) and soluble fibers (5.371.8 vs 6.072.7 g day À1 ; P ¼ 0.011) than patients without MS. In multiple logistic regression models, adjusted for gender and DM duration, variables associated with MS were soluble fibers (OR ¼ 0.86; 95% CI ¼ 0.74-0.98; P ¼ 0.046), soluble fibers from whole-grain foods (OR ¼ 0.43; 95% CI ¼ 0.25-0.76; P ¼ 0.002) and soluble fibers from fruits (OR ¼ 0.76; 95% CI ¼ 0.62-0.95; P ¼ 0.017). Whole-grain and fruits were the foods negatively associated with MS. Conclusions: The intake of soluble fibers, particularly from whole-grain foods and fruits, may have a protective role for the presence of MS in this selected sample of patients with type 2 DM.
Introduction
The metabolic syndrome (MS) refers to a cluster of interrelated risk factors of metabolic origin that is a risk factor for the development of cardiovascular disease and is strongly associated with type 2 diabetes mellitus (DM) (Wilson et al., 2005) . The main metabolic risk factors, probably linked by insulin resistance, are obesity, especially the increase of abdominal fat, disturbed glucose homeostasis, elevated blood pressure, elevated serum triglycerides and reduced HDL cholesterol (National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002; Alberti et al., 2006) .
Although the role of MS as a unique disease has raised many questions and controversies (Gale, 2005; Kahn et al., 2005) , it is clinically useful as it can identify individuals at increase risk for cardiovascular disease. This is particularly important in type 2 DM patients, because MS is present in more than 85% of these patients (Alexander et al., 2003) , and the higher the number of MS components presented, the higher the frequency of coronary artery disease and microvascular chronic diabetic complications (Costa et al., 2003) .
The pathogenesis of MS is not clearly established, but presumably represents a complex interaction between genetic, metabolic and environmental factors (Lidfeldt et al., 2003; Tang et al., 2006) . The role of usual dietary factors was evaluated in subjects with MS (Esposito et al., 2004; Mckeown et al., 2004; Azadbakht et al., 2005; Esmaillzadeh et al., 2005; Freire et al., 2005; Laaksonen et al., 2005; Sahyoun et al., 2006) . The intake of foods with a high glycemic index was associated with insulin resistance and a high prevalence of the MS (Mckeown et al., 2004) . A high intake of whole grains has been negatively associated with MS in healthy individuals (Mckeown et al., 2004) , older adults (Sahyoun et al., 2006) and specific ethnic groups . Total fat intake could be also positively associated with MS, as demonstrated in a population-based study of Japanese descendants living in Brazil (Freire et al., 2005) . Moreover, in a randomized clinical trial, a Mediterranean-style diet rich in fruits, vegetables, nuts, olive oil and whole-grain foods was able to reduce both the prevalence of the MS and its associated cardiovascular risk in patients with MS (Esposito et al., 2004) . However, it is still uncertain which diet component are related to these effects. Also the DASH diet produced a greater improvement in all MS components as compared to a diet to lose weight (Azadbakht et al., 2005) . Furthermore, it was demonstrated that the modification of carbohydrate intake, by consuming a rye bread and pasta-based diet, could also enhance the early insulin secretion in overweight or obese subjects with MS (Laaksonen et al., 2005) .
As far as we know there are no studies that evaluate the influence of diet in MS in patients with type 2 DM. Therefore, the aim of this study was to evaluate possible associations of usual dietary factors with the presence of metabolic syndrome in patients with type 2 DM.
Materials and methods

Patients
This cross-sectional study was conducted in patients with type 2 DM defined as patients over 30 years of age at onset of DM, no previous episode of ketoacidosis or documented ketonuria and treatment with insulin only after 5 years of diagnosis.
Patients attending the outpatient clinic of the Endocrine Division of the Hospital de Clínicas de Porto Alegre, Brazil, who had not received any dietary counseling by a registered dietitian during the previous 6 months, were selected on the basis of the following criteria: BMIo40 kg m
À2
; triglyceride levels o4.53 mmol l
À1
; serum creatinine o176 mmol l À1 ; urinary albumin excretion (UAE) o200 mg min
; normal liver and thyroid function and absence of urinary tract infection, other renal disease and cardiac failure. These criteria were chosen to avoid conditions that might interfere with interpretation of the data. Patients with high triglyceride levels were not included due to inaccuracy in estimating LDL cholesterol by the Friedewald's formula. Patients with decreased renal function and/or macroalbuminuria were also not included as these patients usually receive specific dietary recommendations. For similar reasons, patients with other renal diseases, morbid obesity, liver disease and cardiac failure were also excluded. Medications in use were maintained during the study. Sitting blood pressure was measured twice to the nearest 2 mm Hg, after a 10-min rest, using a standard mercury sphygmomanometer (phases I/V Korotkoff). Physical activity was graded in four levels based on a standardized questionnaire (Tuomilehto et al., 2001) adapted to local habits. Current alcohol intake was categorized as present or absent. Patients were classified as whites or nonwhites (black or mixed) according to their own self-report. According to a random spot urine sample or 24-h timed urine collection, patients were defined as normoalbuminuric (UAE o17 mg l À1 or UAE o20 mg min
) or microalbuminuric (UAE 17-174 mg l À1 or UAE 20-199 mg min À1 ). The diagnosis of microalbuminuria was always confirmed in a 24-h timed urine sample (Gross et al., 2005 ) for women, blood pressure X130/85 mm Hg (or use of antihypertensive drugs) and raised blood glucose or DM (Alberti et al., 2006) . The ethics committee approved the protocol and patients gave their written informed consent.
Dietary assessment
The patient's usual diet was assessed by 3-day weighed-diet record technique (two non-consecutive weekdays and oneweekend days). Patients were issued commercial scales (1-125 g) and measuring cups (25-250 ml) and a detailed explanation and demonstration was given to each subject.
Compliance with the weight-record technique, besides an interview with the nutritionist, was confirmed by comparison of daily protein intake estimated from the 3-day weighed-diet records and from 24-h urinary nitrogen output (1.1770.30 vs 1.1770.35 g kg À1 weight; P ¼ 0.873) (Moulin et al., 1998) . Dietary nutrients from diet records were analyzed using the Nutribase 98 Clinical Nutritional Manager software v.1.0 (Cybersoft Phoenix, AZ, USA). Data intake from nutrients were expressed in crude amounts (g day À1 ), as a percentage of total energy (%) and adjusted to total energy. The food group intakes were also expressed in gram per kilogram of body weight to allow a simple comparison with routine dietary counseling.
Nutrient data on frequently consumed foods were updated if necessary and/or complemented with data obtained from local manufacturers of specific industrialized foods (USDA, 1998). Foods were classified according to their carbohydrate content (%) of crude weight: vegetables from Group A (5%), vegetables from Group B (10%) and vegetables and foods from Group C (20%).
The type and content of dietary fibers was estimated according to the data provided in the CRC Handbook of Dietary Fiber in Human Nutrition (Schakel et al., 2001) . In the present study the food fibers were classified into two major groups depending on their solubility in water.
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Insoluble fibers included lignins, cellulose and some hemicelluloses, and soluble ones, the natural gel-forming fibers, included pectins, gums, mucilages and the remainder of the hemicelluloses.
Anthropometric measurements
The body weight and height of patients (without shoes or coats) were obtained using an anthropometric scale, with measurements recorded to the nearest 100 g for weight and to the nearest 0.1 cm for height. BMI (kg m
À2
) was calculated as weight (kilograms) divided by height (meters) square. Waist circumference was measured midway between the lowest rib margin and the iliac crest, near the umbilicus. Flexible, non-stretch fiberglass tape was used for measurements.
Laboratory measurements
Blood samples were obtained after a 12-h fast. Plasma glucose level was determined by a glucose oxidase method, serum and urinary creatinine level by Jaffe's reaction and the A1C test by an ion-exchange high-performance liquid chromatography procedure (Merck-Hitachi L-9100 glycated hemoglobin analyzer, reference range 4.7-6.0%; Merck Diagnostica, Darmstadt, Germany). Serum total cholesterol and triglycerides were measured by enzymatic-colorimetric methods (Merck Diagnostica; Boeringher Mannheim, Buenos Aires, Argentina), and HDL cholesterol was measured by homogeneous direct method (autoanalyzer, ADVIA 1650). LDL cholesterol was calculated using the Friedewald's formula. UAE was measured in sterile urine samples by immunoturbidimetry (MicroAlb Sera-Pak immuno microalbuminuria; Bayer, Tarrytown, NY, USA on Cobas Mira Plus (Roche Diagnostics Ltd., Rotkreuz, Switzerland); mean intra-assay and inter-assay CVs of 4.5 and 7.6%, respectively).
Statistical analysis
Unpaired Student's t-test, Mann-Whitney's test and w 2 tests were used as appropriated. The mean daily intake of nutrients obtained from 3-day weighed records was used in all statistical analyses. Normally distributed data from dietary intake (g day À1 or mg day À1 ) were adjusted for total energy intake through the residual method. Energy-adjusted nutrient intakes were calculated as the residuals from the regression model, with absolute intake as the dependent variable and total energy intake as the independent variable (Willett and Stampfer, 1986) . Multiple logistic regression analysis was used to calculate the odds ratio (OR) and their respective 95% CIs for the presence of MS, adjusted for gender, duration of DM and physical activity. Results were expressed as means7s.d. or median (range). P-values o0.05 were considered to be statistically significant. Statistical analysis was performed using SPSS 14.0 (SPSS, Chicago, IL, USA).
Results
The clinical and laboratory characteristics of patients divided according to the presence of MS are described in Table 1 . The female sex, the presence of microalbuminuria and coronary artery disease and the use of angiotensin-converting enzyme inhibitors were more frequent, and BMI higher in patients with MS as compared to patients without MS. The proportion of white ethnicity, current smoking and alcohol intake, physical activity, level of education and use of hypolipidemic agents did not differ. Plasma glucose, A1C test, total and LDL cholesterol, creatinine and UAE were not different between the two groups. As expected, features used to define MS were different. Nutrient intakes in patients with and without MS are shown in Table 2 . The crude intake of carbohydrate was lower in patients with MS than in patients without MS, although the significance was not maintained when these values were adjusted for total energy intake or expressed as percent of total energy intake. Intake of protein from vegetable source was lower in patients with MS as compared to patients without MS. The intake of total fat energy adjusted was higher in patients with MS than in patients without MS.
When the daily intake of fibers was evaluated (Table 3) , patients with MS had a reduced ingestion of total, soluble and insoluble fibers, as well as fibers from fruits and from wholegrain foods from Group C (whole-wheat or rye breads, brown rice, whole-wheat pasta, oat bran, whole-wheat crackers). Taken into account, all consumed whole-grain foods, whole-wheat or rye breads were the most frequently (76.7%) consumed food. The intakes of fibers from legumes and beans, and fibers from vegetables did not differ between patients with and without MS.
Multiple logistic regression models were constructed. All models were adjusted for gender and duration of DM. Regarding the intake of particular nutrients, only the intake of protein from vegetable source was associated with MS (OR ¼ 0.94, 95% CI ¼ 0.90-0.98; P ¼ 0.012). Table 4 shows the association of daily intakes of fibers and selected food groups with MS. The intakes of dietary fibers, soluble fibers from whole-grain foods and soluble fibers from fruits and from foods from Group C, particularly whole-grain foods, legumes and beans and fruits were negatively associated with MS. When patients were classified for the presence or absence of MS according the National Cholesterol Education Program criteria (2) the results of these regression models did not change (data not shown).
The associations of soluble fibers from whole-grain foods and from fruits with each component of MS, except the presence of DM, were analyzed. Soluble fibers from wholegrain foods conferred a protection for the presence of abdominal obesity, as evaluated by waist circumference (OR ¼ 0.51, 95% CI ¼ 0.29-0.90; P ¼ 0.022), and for high triglyceride levels (OR ¼ 0.58, 95% CI ¼ 0.36-0.96; P ¼ 0.03). No association with elevated blood pressure levels and with low HDL was observed. No individual component of MS was associated with soluble fibers from fruits.
The tertiles of daily intakes of soluble fibers were 4, 5 and 6 g. The highest tertile of soluble fiber, as compared to the 
Discussion
In the present study, it was observed that a high intake of fibers, especially soluble fibers, was negatively associated with the presence of MS. Daily intake of at least 5 g of soluble fiber was associated with a reduction of 54% for the presence of MS. The main sources of these soluble fibers were wholegrain foods and fruits, and these types of fibers conferred a protection for MS of 57 and 24%, respectively. Whole-grain foods, fruits, legumes and beans were the foods negatively associated with the presence of MS, probably due to their content of soluble fibers (Schakel et al., 2001) . As far as we Fibers and metabolic syndrome in type 2 diabetes mellitus T Steemburgo et al know, no other study evaluated the influence of dietary soluble fibers in MS in patients with type 2 DM. Mechanisms linking beneficial effects of dietary fiber intake on MS features have not been completely established. The effects of soluble fibers on glucose metabolism can be mediated through the slow absorption and digestion of carbohydrates, leading to a reduced demand for insulin (Riccardi and Rivellese, 1991) . Indeed, when type 2 DM patients followed a diet with several foods with high content of soluble fiber, improvements of glycemic and lipid control indexes were associated with a reduction of hiperinsulinemia (Chandalia et al., 2000) . This reduction can be explained by the low glycemic index observed in these foods. Intake of meals with high glycemic index could results in insulin resistance due to direct effects of hyperglycemia, counterregulatory hormone secretion and increased late postprandial serum-free fatty acid levels (Ludwig, 2002) . In fact, insulin resistance and increase prevalence of MS were associated with consumption of high glycemic index foods (Mckeown et al., 2004) .
The food sources of fibers may be relevant as no improvement of metabolic control indexes occurred when only wheat bran was added to the diet of type 2 DM patients (Jenkins et al., 2002) . Furthermore, fibers can also affect blood pressure levels. In patients without DM, a diet rich in soluble fiber induced a moderate blood pressure lowering effect (He et al., 2004) .
The protective role of foods rich in fibers was previously evaluated in patients with MS, but without DM. Observational studies demonstrated that diets rich in whole-grain foods were negatively associated with MS (Mckeown et al., 2004; Esmaillzadeh et al., 2005; Sahyoun et al., 2006) . Reduction of MS features was associated with a Mediterranean-style diet, which is rich in whole grains, fruits, vegetables, legumes, walnuts, fish and olive oil (Esposito et al., 2004) . Also, the improvement of all MS components observed when a DASH diet was compared to a weight reducing diet might be related to fibers from fruits and whole grains (Azadbakht et al., 2005) . However, these studies described only the type of foods consumed, not their fiber content or type of fiber.
In the present study, when the intake of different foods was analyzed, the strongest negative association with MS was observed with whole-grain foods (OR ¼ 0.58). Although the protection for MS from fruits seemed to be lower than wholegrain foods (17 vs 42%), this could be related to a low intake of fruits, approximately two fruits per day, by all patients ; P ¼ 0.350). In this sample of type 2 DM patients, carbohydrate intake and glycemic load were not different in patients with and without MS, as previously demonstrated in subjects without DM (Mckeown et al., 2004) . The dietary glycemic load is the Fibers and metabolic syndrome in type 2 diabetes mellitus T Steemburgo et al product of the glycemic index of a specific food and its carbohydrate content. Glycemic load expresses the interaction of the quality and quantity of carbohydrate in a specific food, and reveals the entire glucose-raising potential of a dietary carbohydrate. In the present study data from glycemic load took into account the total foods consumed daily, and not only fiber-rich foods or even individual meals. Therefore, as there was no difference in the total intake of carbohydrates in patients with and without MS, they had a similar glycemic load. A positive association of the fat intake with MS was observed in non-diabetic Japanese Brazilians (Freire et al., 2005) . In the present study, no relationship of fat intake with MS was demonstrated when multiple regression analysis was performed.
A possible limitation of this study could be related to dietary data records. The food frequency techniques, used in most observational studies, are limited due to the lack of accuracy for quantitative data. However, in the present study, dietary intake was assessed by a standardized 3-day weighed-diet record technique, which includes a 24-h urinary urea measurement to confirm dietary intake estimated from records (Moulin et al., 1998) . Furthermore, the reliability of data from food records was improved by the adjustment of the intake of macronutrients and fibers by total energy intake (Willett and Stampfer, 1986) . Another concern could be related to patient's selection, as exclusion due to some medical conditions, such as macroalbuminuria or hepatic disease, might preclude the generalization of data from the present study. However, inclusion of these patients would have biased the results as they usually received special dietary counseling.
No specific dietary recommendations have been advocated for treatment in type 2 diabetic patients with MS. The present study suggests that a high intake of foods rich in soluble fiber, such as most whole-grain foods (whole-wheat or rye breads, and oat bran), fruits (orange, papaya, mango, tangerine), vegetables (broccoli, carrots, cauliflower), legumes and beans could be recommended to these patients to improve the profile of MS components, especially triglycerides and HDL cholesterol. A randomized clinical trial is needed to confirm the beneficial effects of soluble fiber on MS in patients with MS, particularly in type 2 DM patients.
In conclusion, the intake of soluble fibers, especially from whole-grain foods and from fruits, may have a protective role for the presence of MS in this selected sample of patients with type 2 DM.
